EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Anti-VEGF Agents Clearance Through the Aqueous Outflow Pathway in a Rat Model

Assaf Ben-Arzi, Itay Spector, Yariv Keshet, Orly Gal-Or, Irit Bahar, Assaf Dotan

Investigative Ophthalmology & Visual Science · 2025

DOI: 10.1167/iovs.66.6.1 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2025. Written by Assaf Ben-Arzi and 5 co-authors. Institution: Department of Ophthalmology, Rabin Medical Center, Petach Tikva, Israel. Major MEDLINE topics: Vascular Endothelial Growth Factor A, Angiogenesis Inhibitors, Aqueous Humor, Recombinant Fusion Proteins. Cited 2 times so far (Crossref); 36 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Sustained increase in intraocular pressure (IOP) following intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) in the treatment of retinal disease has been theoretically attributed to aggregation of anti-VEGF in the iridocorneal angle. However, previous studies by our group showed full clearance of intravitreally injected bevacizumab, aflibercept, and ranibizumab. The objective of this study was to further analyze and compare the clearance of these anti-VEGF agents from the eye after a single injection in a rat model.

Methods

Brown Norway rats received an intravitreal injection of 3 µl anti-VEGF at the standard concentration 3 days following induction of choroidal neovascularization. The eyes were processed at 0, 3, 6, 24, and 48 hours thereafter, and immunofluorescence was evaluated with confocal microscopy and 3D reconstruction analysis. The signal concentration was calculated, and the drug clearance rate was measured. The immunohistochemistry process was validated with negative and positive control groups.

Results

The immunofluorescent signal was positive for all anti-VEGF agents at the trabecular meshwork, Schlemm's canal, and episcleral veins. Anti-VEGF immunostaining peaked immediately after injection and then decreased gradually to negligible at 48 hours (P 0.05). The clearance rate of anti-VEGF from the iridocorneal angle ranged between 98.68% and 99.87% at 48 hours.

Conclusions

Bevacizumab, aflibercept, and ranibizumab cleared completely from the iridocorneal angle at 48 hours in the brown Norway rats following a single intravitreal injection and with similar a clearance rate. These findings support our earlier studies refuting the anti-VEGF aggregation hypothesis.

Subjects

MeSH terms (MEDLINE)

Vascular Endothelial Growth Factor AAngiogenesis InhibitorsAqueous HumorRecombinant Fusion ProteinsChoroidal NeovascularizationAnimalsRatsIntravitreal InjectionsBevacizumabRats, Inbred BNDisease Models, AnimalRanibizumabReceptors, Vascular Endothelial Growth FactorMicroscopy, ConfocalTrabecular MeshworkIntraocular PressureMale

Substances

Vascular Endothelial Growth Factor AAngiogenesis InhibitorsBevacizumabafliberceptRanibizumabReceptors, Vascular Endothelial Growth FactorRecombinant Fusion Proteins

Authors and institutions

  • Department of Ophthalmology, Rabin Medical Center, Petach Tikva, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Histospeck LTD Labs, Tel-Aviv, Israel.

Cite

APA

Ben-Arzi, A., Spector, I., Keshet, Y., Gal-Or, O., Bahar, I., & Dotan, A. (2025). Anti-VEGF Agents Clearance Through the Aqueous Outflow Pathway in a Rat Model. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.6.1

Vancouver

Ben-Arzi A, Spector I, Keshet Y, Gal-Or O, Bahar I, Dotan A. Anti-VEGF Agents Clearance Through the Aqueous Outflow Pathway in a Rat Model. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.6.1

BibTeX
@article{BenArzi2025,
  author = {Ben-Arzi, Assaf and Spector, Itay and Keshet, Yariv and Gal-Or, Orly and Bahar, Irit and Dotan, Assaf},
  title = {Anti-VEGF Agents Clearance Through the Aqueous Outflow Pathway in a Rat Model},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2025},
  doi = {10.1167/iovs.66.6.1}
}
Start for free →